Creativity Awards Class of 2009
Creativity Award
Development and Validation of Selective Small Molecule ETS Factor Inhibitors for Prostate Cancer—Understanding Gene Activity that Likely Causes Up to 60 Percent of Prostate Cancer Cases Can Open Door to New Drug Development—Another Approach
Towia Libermann, PhD, Alan Rigby, PhD
Beth Israel Deaconess Medical Center
The Dan Fogelberg Creativity Award
PSMA-based Microfluidics-Capture of Circulating Prostate Cancer Cells: Study of Microtubule-driven Androgen Receptor Signaling, Gene Fusion, and Gene Expression Profiles with Correlation to Clinical Response to Taxane Therapy—New Capture Technology for Circulating Tumor Cells Supported by PCF-Funding May Prove Useful in Identifying Patients Most Likely to Benefit from Taxotere.
David Nanus, MD
Weill Cornell Medical College
Creativity Award
Pro-Senescence Therapy for Cancer: A Novel Approach Towards Prostate Cancer Prevention and Cure—Identifying New Druggable Targets May Enable Scientists to Lull Prostate Cancer Cells to Sleep
Pier Paolo Pandolfi, MD, PhD
Beth Israel Deaconess Medical Center
The Arnie’s Army Creativity Award
Exosomal RNAs as Serum Prostate Cancer Biomarkers—Personalized Treatment and Better Prognostic Indicators May Become Reality Through MicroRNA Tumor Profiling
Muneesh Tewari, MD, PhD
Fred Hutchinson Cancer Research Center and University of Washington
The William Bikoff Creativity Award
Noninvasive Radiofrequency Field for the Targeted Destruction of Prostate Cancer Using Directed Gold Nanoparticles—Activated Gold Particles Could Provide Novel Means of Destroying Tumors
John F. Ward, MD – The University of Texas MD Anderson Cancer Center